Literature DB >> 21454397

The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD.

Andreas von Leupoldt1, Karin Taube2, Kirsten Lehmann2, Anja Fritzsche3, Helgo Magnussen4.   

Abstract

BACKGROUND: Anxiety and depression are prevalent comorbidities in COPD and are related to a worse course of disease. The present study examined the impact of anxiety and depression on functional performance, dyspnea, and quality of life (QoL) in patients with COPD at the start and end of an outpatient pulmonary rehabilitation (PR) program.
METHODS: Before and after PR, 238 patients with COPD (mean FEV(1) % predicted = 54, mean age = 62 years) underwent a 6-min walking test (6MWT). In addition, anxiety, depression, QoL, and dyspnea at rest, after the 6MWT, and during activities were measured.
RESULTS: Except for dyspnea at rest, improvements were observed in all outcome measures after PR. Multiple regression analyses showed that before and after PR, anxiety and depression were significantly associated with greater dyspnea after the 6MWT and during activities and with reduced QoL, even after controlling for the effects of age, sex, lung function, and smoking status. Moreover, before and after PR, anxiety was related to greater dyspnea at rest, whereas depression was significantly associated with reduced functional performance in the 6MWT.
CONCLUSIONS: This study demonstrates that anxiety and depression are significantly associated with increased dyspnea and reduced functional performance and QoL in patients with COPD. These negative associations remain stable over the course of PR, even when improvements in these outcomes are achieved during PR. The results underline the clinical importance of detecting and treating anxiety and depression in patients with COPD.

Entities:  

Mesh:

Year:  2011        PMID: 21454397     DOI: 10.1378/chest.10-2917

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  35 in total

Review 1.  How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.

Authors:  Leonardo M Fabbri; Cynthia Boyd; Piera Boschetto; Klaus F Rabe; A Sonia Buist; Barbara Yawn; Bruce Leff; David M Kent; Holger J Schünemann
Journal:  Proc Am Thorac Soc       Date:  2012-12

Review 2.  Integrative Medicine for Respiratory Conditions: Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Gloria Y Yeh; Randy Horwitz
Journal:  Med Clin North Am       Date:  2017-06-21       Impact factor: 5.456

3.  The Epidemiology of Depressive Symptoms in the Last Year of Life.

Authors:  Elissa Kozlov; XinQi Dong; Amy S Kelley; Claire K Ankuda
Journal:  J Am Geriatr Soc       Date:  2019-11-05       Impact factor: 5.562

4.  Association of depression with disease severity in patients with chronic obstructive pulmonary disease.

Authors:  Ki Uk Kim; Hye-Kyung Park; Hee Young Jung; Jong-Joon Ahn; Eunsoo Moon; Yun Seong Kim; Min Ki Lee; Haejung Lee
Journal:  Lung       Date:  2014-01-07       Impact factor: 2.584

5.  Childhood physical abuse and respiratory disease in the community: the role of mental health and cigarette smoking.

Authors:  Renee D Goodwin; Frederick S Wamboldt
Journal:  Nicotine Tob Res       Date:  2011-10-24       Impact factor: 4.244

6.  The prospective association of perceived criticism with dyspnea in chronic lung disease.

Authors:  Kristen E Holm; Frederick S Wamboldt; Dee W Ford; Robert A Sandhaus; Matthew Strand; Charlie Strange; Karin F Hoth
Journal:  J Psychosom Res       Date:  2013-02-28       Impact factor: 3.006

7.  Patients with COPD with higher levels of anxiety are more physically active.

Authors:  Huong Q Nguyen; Vincent S Fan; Jerald Herting; Jungeun Lee; Musetta Fu; Zijing Chen; Soo Borson; Ruth Kohen; Gustavo Matute-Bello; Genevieve Pagalilauan; Sandra G Adams
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

Review 8.  Depression and anxiety in patients with COPD.

Authors:  Abebaw M Yohannes; George S Alexopoulos
Journal:  Eur Respir Rev       Date:  2014-09

9.  Frequent Exacerbator: The Phenotype at Risk of Depressive Symptoms in Geriatric COPD Patients.

Authors:  Hoi Nam Tse; Cee Zhung Steven Tseng; King Ying Wong; Lai Yun Ng; Tin Lok Lai; Kwok Sang Yee
Journal:  Lung       Date:  2016-05-02       Impact factor: 2.584

Review 10.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Authors:  Nirupama Putcha; M Bradley Drummond; Robert A Wise; Nadia N Hansel
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.